Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

References for PMC Articles for PubMed (Select 19770621)

1.

Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study.

Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, Lambotte O, Avettand-Fenoel V, Le Clerc S, de Senneville LD, Deveau C, Boufassa F, Debré P, Delfraissy JF, Broet P, Theodorou I; ANRS Genome Wide Association 01.

PLoS One. 2008;3(12):e3907. doi: 10.1371/journal.pone.0003907. Epub 2008 Dec 24.

2.

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.

Moreno S, Jarrin I, Iribarren JA, Perez-Elías MJ, Viciana P, Parra-Ruiz J, Gomez-Sirvent JL, Lopez-Aldeguer J, Gutierrez F, Blanco JR, Vidal F, Leal M, Rodríguez Arenas MA, Del Amo J; CoRIS-MD.

Int J Tuberc Lung Dis. 2008 Dec;12(12):1393-400. Erratum in: Int J Tuberc Lung Dis. 2009 Jan;13(1):150. Parra, J [corrected to Parra-Ruiz, J].

PMID:
19017448
3.

[Mortality rate of HIV-infected adults compared with the general population: long-term and CD4-lymphocyte-dependent results].

Lewden C, Chêne G, Morlat P, Raffi F, Dabis F, Leport C; Les Groupes d'étude des Cohortes Anrs Co3 Aquitaine Et Anrs Co8 Aproco-Copilote.

Med Sci (Paris). 2008 Oct;24(10):804-6. doi: 10.1051/medsci/20082410804. French. No abstract available.

4.

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD; INSIGHT SMART Study Group.

PLoS Med. 2008 Oct 21;5(10):e203. doi: 10.1371/journal.pmed.0050203.

5.

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.

Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, Costagliola D, Mary-Krause M; FHDH-ANRS CO 4.

AIDS. 2008 Jun 19;22(10):1203-11. doi: 10.1097/QAD.0b013e3283023f78.

PMID:
18525266
6.

Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).

Jaén A, Esteve A, Miró JM, Tural C, Montoliu A, Ferrer E, Riera M, Segura F, Force L, Sued O, Vilaró J, Garcia I, Masabeu A, Altès J, Coltet B, Podzamczer D, Murillas J, Navarro G, Gatell JM, Casabona J; PISCIS Study Group.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):212-20.

PMID:
18297762
7.

Survival following HIV infection of a cohort followed up from seroconversion in the UK.

Ewings FM, Bhaskaran K, McLean K, Hawkins D, Fisher M, Fidler S, Gilson R, Nock D, Brettle R, Johnson M, Phillips A, Porter K; UK Register of HIV Seroconverters.

AIDS. 2008 Jan 2;22(1):89-95.

PMID:
18090396
8.

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, Montaner JS.

AIDS. 2007 Mar 30;21(6):685-92.

PMID:
17413689
9.

[Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].

Caro-Murillo AM, Castilla J, Pérez-Hoyos S, Miró JM, Podzamczer D, Rubio R, Riera M, Viciana P, López Aldeguer J, Iribarren JA, de los Santos-Gil I, Gómez-Sirvent JL, Berenguer J, Gutiérrez F, Saumoy M, Segura F, Soriano V, Peña A, Pulido F, Oteo JA, Leal M, Casabona J, del Amo J, Moreno S; Grupo de trabajo de la Cohorte de la Red de Investigación en Sida (CoRIS).

Enferm Infecc Microbiol Clin. 2007 Jan;25(1):23-31. Spanish.

PMID:
17261243
10.

Survival of persons with and without HIV infection in Denmark, 1995-2005.

Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, Vaeth M, Obel N.

Ann Intern Med. 2007 Jan 16;146(2):87-95.

PMID:
17227932
11.

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.

Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV.

Ann Intern Med. 2006 Sep 19;145(6):397-406.

PMID:
16983127
12.

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, Dabis F, Gill J, Lundgren J, Hogg RS, de Wolf F, Fätkenheuer G, Staszewski S, d'Arminio Monforte A, Egger M; Antiretroviral Therapy (ART) Cohort Collaboration.

Lancet. 2006 Aug 5;368(9534):451-8. Review.

PMID:
16890831
13.

Veterans Aging Cohort Study (VACS): Overview and description.

Justice AC, Dombrowski E, Conigliaro J, Fultz SL, Gibson D, Madenwald T, Goulet J, Simberkoff M, Butt AA, Rimland D, Rodriguez-Barradas MC, Gibert CL, Oursler KA, Brown S, Leaf DA, Goetz MB, Bryant K.

Med Care. 2006 Aug;44(8 Suppl 2):S13-24.

14.

Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.

Pérez-Hoyos S, Ferreros I, del Amo J, Muga R, del Romero J, de Olalla PG, Hernández-Aguado I.

AIDS. 2006 Jan 9;20(2):289-91.

PMID:
16511426
15.

Mortality among urban drug users and the impact of highly active antiretroviral therapy.

Celentano DD.

Clin Infect Dis. 2005 Sep 15;41(6):873-4. Epub 2005 Aug 16. No abstract available.

16.

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Sterne JA, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, Rickenbach M, Robins JM, Egger M; Swiss HIV Cohort Study.

Lancet. 2005 Jul 30-Aug 5;366(9483):378-84.

PMID:
16054937
17.

Does transient HAART during primary HIV-1 infection lower the virological set-point?

Desquilbet L, Goujard C, Rouzioux C, Sinet M, Deveau C, Chaix ML, Séréni D, Boufassa F, Delfraissy JF, Meyer L; PRIMO and SEROCO Study Groups.

AIDS. 2004 Dec 3;18(18):2361-9.

PMID:
15622312
18.

A structural approach to selection bias.

Hernán MA, Hernández-Díaz S, Robins JM.

Epidemiology. 2004 Sep;15(5):615-25.

PMID:
15308962
19.

HIV survival benefit associated with earlier antiviral therapy.

Mocroft A, Phillips AN, Lundgren JD.

Ann Intern Med. 2004 Apr 6;140(7):578-9; author reply 579. No abstract available.

PMID:
15068990
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk